Cargando…

Evidence-Based Criteria Supporting Early Discharge for Pediatric Patients With Osteosarcoma Receiving High-Dose Methotrexate: A Retrospective Chart Review

PURPOSE: The purpose of this study is to describe the outcomes following the implementation of an early discharge protocol for pediatric patients with osteosarcoma receiving high-dose methotrexate (MTX) to determine if the protocol safely decreased length of stay without increased toxicity. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Armideo, Erin, Froio, Shannon, Johnson, Meredith, Tardino-Gingrich, Alison, Froh, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press LLC 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955567/ https://www.ncbi.nlm.nih.gov/pubmed/35369399 http://dx.doi.org/10.6004/jadpro.2022.13.2.5

Ejemplares similares

Influence of genetic polymorphisms in the folate pathway on toxicity after high-dose methotrexate treatment in pediatric osteosarcoma
por: Park, Jeong A, et al.
Publicado: (2016)

Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma
por: Hegyi, Marta, et al.
Publicado: (2016)

Two Pediatric Osteosarcoma Cases with Delayed Methotrexate Excretion: Its Clinical Course and Management
por: Lee, Kang Min, et al.
Publicado: (2011)

Delayed High-dose Methotrexate Excretion and Influencing Factors in Osteosarcoma Patients
por: Zhang, Wei, et al.
Publicado: (2016)

Nomogram predicting leukopenia in osteosarcoma after high-dose methotrexate chemotherapy
por: Wu, Haixiao, et al.
Publicado: (2022)

Identification of genes associated with methotrexate resistance in methotrexate-resistant osteosarcoma cell lines
por: Yang, Xiao-rong, et al.
Publicado: (2015)

Immunotherapy for High-Risk Neuroblastoma: Management of Side Effects and Complications
por: Armideo, Erin, et al.
Publicado: (2017)

Patient-derived osteosarcoma cells are resistant to methotrexate
por: dos Santos Cavalcanti, Amanda, et al.
Publicado: (2017)

Renal Function and Plasma Methotrexate Concentrations Predict Toxicities in Adults Receiving High-Dose Methotrexate
por: Yang, Yunyun, et al.
Publicado: (2018)

Safety and efficacy of high‐dose methotrexate for osteosarcoma in adolescents compared with young adults
por: Wippel, Brittany, et al.
Publicado: (2018)

Impairment of Methotrexate Transport Is Common in Osteosarcoma Tumor Samples
por: Sowers, Rebecca, et al.
Publicado: (2011)

MTHFR variant is associated with high-dose methotrexate-induced toxicity in the Chinese osteosarcoma patients
por: Xu, Leilei, et al.
Publicado: (2018)

A Prospective Evaluation of Novel Renal Biomarkers in Patients With Lymphoma Receiving High-Dose Methotrexate
por: Barreto, Jason N., et al.
Publicado: (2022)

Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia
por: Liu, Shu-Guang, et al.
Publicado: (2017)

Pathological responses to preoperative high-dose methotrexate chemotherapy in osteosarcoma--experience in Korea cancer hospital.
por: Lee, S. Y., et al.
Publicado: (1993)

Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab
por: Burmester, Gerd R, et al.
Publicado: (2017)

Mechanisms of methotrexate resistance in osteosarcoma cell lines and strategies for overcoming this resistance
por: WANG, JIANJUN, et al.
Publicado: (2015)

Methotrexate Free Chemotherapy and Limb Salvage Surgery for Paediatric Osteosarcoma in India
por: Sukumaran, Reghu Kesavapillai, et al.
Publicado: (2018)

MTHFR Polymorphism Is Associated With Severe Methotrexate-Induced Toxicity in Osteosarcoma Treatment
por: Zhang, Wenchao, et al.
Publicado: (2021)

Co-Delivery of Methotrexate and Nanohydroxyapatite with Polyethylene Glycol Polymers for Chemotherapy of Osteosarcoma
por: Ou, Lingbin, et al.
Publicado: (2023)

Efficacy of high dose methotrexate in pediatric auto-immune uveitis
por: Armbrust, Wineke, et al.
Publicado: (2014)

Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma
por: Michelagnoli, M P, et al.
Publicado: (1999)

Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis
por: Rossi, Barbara, et al.
Publicado: (2010)

Stroke-like encephalopathy following high-dose intravenous methotrexate in an adolescent with osteosarcoma: a case report
por: Valle, Daniel Almeida do, et al.
Publicado: (2016)

More severe toxicity of genetic polymorphisms on MTHFR activity in osteosarcoma patients treated with high-dose methotrexate
por: Xie, Lu, et al.
Publicado: (2017)

Opioid prescribing practices in trauma patients at discharge: An exploratory retrospective chart analysis
por: Premachandran, Priyanka, et al.
Publicado: (2022)

Effect of co‐medications and potential risk factors of high‐dose methotrexate‐mediated acute hepatotoxicity in patients with osteosarcoma
por: Wang, Sheng‐Fan, et al.
Publicado: (2023)

Incidence and Risk Factors of Hepatic Fibrosis in Psoriatic Patients Receiving Methotrexate with Concomitant Acitretin Therapy and Methotrexate Monotherapy
por: Rattanakaemakorn, Ploysyne, et al.
Publicado: (2021)

Acute Kidney Injury with SARS-CoV-2 Infection in Pediatric Patients Receiving High-Dose Methotrexate Chemotherapy: A Report of Three Cases
por: Nigro, Olga, et al.
Publicado: (2023)

Doxorubicin Dose Deintensification in Pediatric Osteosarcoma, Is Less Better?
por: Halalsheh, Hadeel, et al.
Publicado: (2023)

The effect of intravenous hydration strategy on plasma methotrexate clearance during intravenous high-dose methotrexate administration in pediatric oncology patients
por: Traivaree, Chanchai, et al.
Publicado: (2018)

High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia: Predictors of Delayed Clearance and the Effect of Increased Hydration Rate on Methotrexate Clearance
por: Chen, Aaron R, et al.
Publicado: (2020)

Hospital course and discharge criteria for children hospitalized with bronchiolitis
por: Mansbach, Jonathan M., et al.
Publicado: (2015)

DHFR-mediated effects of methotrexate in medulloblastoma and osteosarcoma cells: The same outcome of treatment with different doses in sensitive cell lines
por: NERADIL, JAKUB, et al.
Publicado: (2015)

Population Pharmacokinetics of High-dose Methotrexate After Intravenous Administration in Chinese Osteosarcoma Patients from a Single Institution
por: Zhang, Wei, et al.
Publicado: (2015)

Methotrexate-associated lymphoproliferative disorder of the thoracic spine in a patient with rheumatoid arthritis receiving methotrexate: a case report
por: Kamio, Satoshi, et al.
Publicado: (2021)

Pediatric Collagenous Gastroenterocolitis Successfully Treated with Methotrexate
por: Beinvogl, Beate C., et al.
Publicado: (2020)

Safe Discharge Criteria After Curative Gastrectomy for Gastric Cancer
por: Guner, Ali, et al.
Publicado: (2022)

Educational Case: Pediatric Osteosarcoma
por: Rogers, Kelly M., et al.
Publicado: (2019)

Pediatric Osteosarcoma: An Updated Review
por: Taran, Shachi Jain, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n4dkgb9iub5t6sf8u17g42fhc0